Is my portfolio
One Report to Answer all your Questions!
Biogen Pharmachem - Quaterly Results
Date: 08-11-2025
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2025 is Rs. -4.91 millions as compared to Net Loss of Rs. -9.96 millions of corresponding quarter ended September 2024 Operating profit Margin for the quarter ended September 2025 improved to -4.91% as compared to -9.96% of corresponding quarter ended September 2024
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202509 | 202409 | % Var | 202509 | 202409 | % Var | 202503 | 202403 | % Var | |
| Sales | 0.00 | 0.00 | 0.00 | 15.43 | -0.91 | -1795.60 | 8.38 | 23.82 | -64.82 |
| Other Income | -1.05 | -6.50 | -83.85 | -1.05 | -6.50 | -83.85 | 0.00 | 0.00 | 0.00 |
| PBIDT | -4.91 | -9.96 | -50.70 | 8.54 | -11.55 | -173.94 | -2.93 | 19.31 | -115.17 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -4.91 | -9.96 | -50.70 | 8.54 | -11.55 | -173.94 | -2.93 | 19.31 | -115.17 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBT | -4.91 | -9.96 | -50.70 | 8.54 | -11.55 | -173.94 | -2.93 | 19.31 | -115.17 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -4.91 | -9.96 | -50.70 | 8.54 | -11.55 | -173.94 | -2.93 | 19.31 | -115.17 |
| Equity | 902.60 | 652.60 | 38.31 | 902.60 | 652.60 | 38.31 | 652.60 | 652.60 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 55.35 | 1269.23 | -95.64 | -34.96 | 81.07 | -143.13 |